BackOKYO Pharma Limited Overview

OKYO Pharma Limited Other Liabilities

OKYO Pharma Limited's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

OKYO Pharma Limited Other Liabilities History

Loading

OKYO Pharma Limited vs. peers: Other Liabilities Comparison

Loading

OKYO Pharma Limited Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

OKYO Pharma Limited (OKYO) FAQ

OKYO Pharma Limited (OKYO) currently reports a other liabilities of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore OKYO Pharma Limited's other liabilities history and peer comparisons.

OKYO Pharma Limited's other liabilities changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OKYO Pharma Limited reported $0 in other liabilities as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OKYO Pharma Limited, and consider following OKYO for alerts when major investors trade the stock.

OKYO Pharma Limited is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OKYO with unrelated industries.